Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma

Molecular Biology Reports

Volumn 36, Issue 1, 2009, Pages 153-158

  Nathan, Saminathan S ^a   Pereira, Barry P ^a   Zhou, Ye Fang ^a   Gupta, Anurag ^a   Dombrowski, Christian ^b   Soong, Ritchie ^a   Pho, Robert W H ^a   Stein, Gary S ^c   Salto Tellez, Manuel ^a   Cool, Simon M ^b   Van Wijnen, Andre J ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Human osteosarcoma; Osteoblast; p53 p21 pathway; pRB gene; Runx2

Indexed keywords

TRANSCRIPTION FACTOR RUNX2;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL TYPE; GENOMIC INSTABILITY; MUTATION; OSTEOBLAST; OSTEOSARCOMA; OSTEOSARCOMA CELL; PROTEIN EXPRESSION;

CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, FLUORESCENCE; OSTEOBLASTS; OSTEOSARCOMA; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 56649109716     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-008-9378-1     Document Type: Article

References (22)

1. KM Kim R Salovaara JP Mecklin HJ Järvinen LA Aaltonen D Shibata 2002 PolyA deletions in hereditary nonpolyposis colorectal cancer: mutations before a gatekeeper Am J Pathol 160 1503 1506
2. CP Gibbs VG Kukekov JD Reith O Tchigrinova ON Suslov EW Scott SC Ghivizzani TN Ignatova DA Steindler 2005 Stem-like cells in bone sarcomas: implications for tumorigenesis Neoplasia 7 11 967 976 10.1593/neo.05394
3. K Blyth ER Cameron JC Neil 2005 The RUNX genes: gain or loss of function in cancer Nat Rev Cancer 5 376 387 10.1038/nrc1607
4. M Kansara DM Thomas 2007 Molecular pathogenesis of osteosarcoma DNA Cell Biol 26 1 18 10.1089/dna.2006.0505
5. J Pratap A Javed LR Languino AJ van Wijnen JL Stein GS Stein JB Lian 2005 The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion Mol Cell Biol 25 8581 8591 10.1128/MCB.25.19.8581-8591.2005
6. DM Thomas SA Johnson NA Sims MK Trivett JL Slavin BP Rubin P Waring GA McArthur CR Walkley AJ Holloway D Diyagama JE Grim BE Clurman DD Bowtell JS Lee GM Gutierrez DM Piscopo SA Carty PW Hinds 2004 Terminal osteoblast differentiation, mediated by Runx2 and p27KIP1, is disrupted in osteosarcoma J Cell Biol 167 925 934 10.1083/jcb.200409187
7. DM Thomas SA Carty DM Piscopo JS Lee WF Wang WC Forrester PW Hinds 2001 The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation Mol Cell 8 303 316 10.1016/S1097-2765(01)00327-6
8. S Gupta MX Luong SA Bleuming A Miele M Luong D Young ES Knudsen AJ Van Wijnen JL Stein GS Stein 2003 Tumor suppressor pRB functions as a co-repressor of the CCAAT displacement protein (CDP/cut) to regulate cell cycle controlled histone H4 transcription J Cell Physiol 196 541 556 10.1002/jcp.10335
9. EA Harrington JL Bruce E Harlow N Dyson 1998 pRB plays an essential role in cell cycle arrest induced by DNA damage Proc Natl Acad Sci USA 95 11945 11950 10.1073/pnas.95.20.11945
10. CN Mayhew EE Bosco SR Fox T Okaya P Tarapore SJ Schwemberger GF Babcock AB Lentsch K Fukasawa ES Knudsen 2005 Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy Cancer Res 65 4568 4577 10.1158/0008-5472.CAN-04-4221
11. B Fuchs DJ Pritchard 2002 Etiology of osteosarcoma Clin Orthop Relat Res 397 40 52 10.1097/00003086-200204000-00007
12. M Galindo J Pratap DW Young H Hovhannisyan HJ Im JY Choi JB Lian JL Stein GS Stein AJ van Wijnen 2005 The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts J Biol Chem 280 20274 20285 10.1074/jbc.M413665200
13. JB Lian A Javed SK Zaidi C Lengner M Montecino AJ van Wijnen JL Stein GS Stein 2004 Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors Crit Rev Eukaryot Gene Expr 14 1 41 10.1615/CritRevEukaryotGeneExpr.v14.i12.10
14. J Pratap M Galindo SK Zaidi D Vradii BM Bhat JA Robinson JY Choi T Komori JL Stein JB Lian GS Stein AJ van Wijnen 2003 Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts Cancer Res 63 5357 5362
15. M Qiao P Shapiro M Fosbrink H Rus R Kumar A Passaniti 2006 Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation J Biol Chem 281 7118 7128 10.1074/jbc.M508162200
16. R Shen X Wang H Drissi F Liu RJ O'Keefe D Chen 2006 Cyclin D1-cdk4 induces runx2 ubiquitination and degradation J Biol Chem 281 16347 16353 10.1074/jbc.M603439200
17. AL Gartel C Feliciano AL Tyner 2003 A new method for determining the status of p53 in tumor cell lines of different origin Oncol Res 13 405 408
18. LE Giono JJ Manfredi 2006 The p53 tumor suppressor participates in multiple cell cycle checkpoints J Cell Physiol 209 13 20 10.1002/jcp.20689
19. X Chen LJ Ko L Jayaraman C Prives 1996 p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells Genes Dev 10 2438 2451 10.1101/gad.10.19.2438
20. CJ Lengner HA Steinman J Gagnon TW Smith JE Henderson BE Kream GS Stein JB Lian SN Jones 2006 Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling J Cell Biol 172 6 909 921 10.1083/jcb.200508130
21. X Wang HY Kua Y Hu K Guo Q Zeng Q Wu HH Ng G Karsenty B de Crombrugghe J Yeh B Li 2006 p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling J Cell Biol 172 1 115 125 10.1083/jcb.200507106
22. JJ Westendorf SK Zaidi JE Cascino R Kahler AJ van Wijnen JB Lian M Yoshida GS Stein X Li 2002 Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter Mol Cell Biol 22 7982 7992 10.1128/MCB.22.22.7982-7992.2002